Zimmer Biomet Holdings, Inc. (ZBH)
Zimmer Biomet Holdings, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Warsaw, IN, US. The stock last traded at $96.37, down 0.88% on the session, giving a market capitalisation of $18.64B. On trailing twelve-month figures it carries a trailing P/E of 23.33, a net margin of 9.5%. Its beta of 0.46 implies it has historically moved less than the broad market.
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Zimmer Biomet Holdings, Inc. is most often compared with the following Healthcare names: